Skip to content

EBIT at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$18.41M+34.1%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$6.2M+32.1%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-$4.41M+35.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-$34.62M-74.9%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$32.16M-81.7%
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's EBIT?
Lucid Diagnostics (LUCD) reported EBIT of -$12.11M in Q1 2026.
How has Lucid Diagnostics's EBIT changed year-over-year?
Lucid Diagnostics's EBIT increased by 3.0% year-over-year, from -$12.49M to -$12.11M.
What is the long-term trend for Lucid Diagnostics's EBIT?
Over 4 years (2021 to 2025), Lucid Diagnostics's EBIT has grown at a 16.0% compound annual growth rate (CAGR), from -$27.42M to -$49.64M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.